CHEK2 and complete blood cell count: One case‐only study showed a non‐significant increased risk for developing CBC after treatment with radiotherapy in CHEK2 c.1100delC carriers versus non‐carriers, but due to the small study size, the associations in the younger population could not be investigated.13